Publication | Closed Access

Phase II Study of Long-Term Androgen Suppression With Bevacizumab and Intensity-Modulated Radiation Therapy (IMRT) in High-Risk Prostate Cancer

Long-term Androgen SuppressionUrologyRadiation MedicineHigh-risk Prostate CancerRadiation TherapyMedicinePhase Ii StudyProstatic DiseaseOncologyRadiation Oncology